Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...
Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study) Receipt of previous ...
Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...
Drug discovery can be an uphill battle, especially lately given recent upheaval at the FDA and muted investment activity. BioSpace spoke to four industry executives about key issues facing those ...
As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed. In this podcast, Anil Diwan, President and Executive Chairman of ...
Recent health news highlights innovations and challenges in pharmaceuticals: Incyte reports success in skin disease treatment trials, Insilico Medicine secures a lucrative partnership with Eli Lilly ...
The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Dr. William Maguire discussing regulatory considerations related to PSMA PET imaging in clinical trials.
Hosted on MSN
Leen Kawas on AI and drug discovery: The ethical challenges that will define the next decade
In the biotechnology sector, artificial intelligence (AI) has emerged as a transformative force with profound implications for drug discovery and development. According to biotech leader Leen Kawas, ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results